Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Osteoporos Int. 2011 Sep 9;23(3):821–828. doi: 10.1007/s00198-011-1757-0

Table 3.

Unadjusted and adjusteda relative risk estimates with their 95% confidence interval (CI) for future fracture by site in women with rib fracture history 0compared to no fracture history

Future fx site Relative risk (95% CI) for future fracture by specific future fracture site
Rib
Hip
Spine
Wrist
Forearm
Any fracture
Age group (years) Unadj Adj Unadj Adj Unadj Adj Unadj Adj Unadj Adj Unadj Adj
50–59 (N=59,227) 9.7 (7.8–12.1) 7.2 (5.8–9.0) 2.3 (0.9–5.6) 1.6 (0.7–4.0) 3.2 (1.9–5.3) 2.3 (1.4–3.9) 2.1 (1.5–3.2) 1.7 (1.1–2.4) 1.1 (0.4–2.9) 0.9 (0.3–2.4) 4.4 (3.7–5.3) 3.4 (2.8–4.0)
60–69 (N=54,175) 6.9 (5.5–8.7) 5.5 (4.4–6.9) 1.4 (0.7–2.6) 1.0 (0.6–1.9) 3.3 (2.3–4.8) 2.6 (1.8–3.8) 1.8 (1.3–2.4) 1.4 (1.03–2.0) 1.7 (0.9–3.4) 1.5 (0.8–2.9) 3.1 (2.6–3.6) 2.5 (2.1–3.0)
70–79 (N=34,585) 5.1 (4.1–6.4) 4.3 (3.4–5.3) 1.7 (1.2–2.5) 1.4 (0.9–2.0) 2.1 (1.5–3.0) 1.7 (1.2–2.4) 1.5 (1.1–2.1) 1.2 (0.9–1.7) 0.9 (0.4–2.0) 0.8 (0.3–1.7) 2.4 (2.1–2.8) 2.0 (1.7–2.3)
80+ (N=7,044) 5.0 (3.4–7.2) 4.5 (3.1–6.6) 1.1 (0.6–2.1) 1.0 (0.6–1.9) 2.5 (1.4–4.4) 2.2 (1.3–3.9) 1.5 (0.9–2.6) 1.3 (0.7–2.3) 1.6 (0.6–4.5) 1.5 (0.5–4.1) 2.2 (1.7–2.9) 2.0 (1.6–2.6)
Overallb 7.2 (6.4–8.1) 5.4 (4.8–6.1) 2.1 (1.6–2.8) 1.2 (0.9–1.6) 3.1 (2.5–3.9) 2.1 (1.7–2.6) 1.9 (1.6–2.3) 1.4 (1.1–1.7) 1.4 (0.9–1.7) 1.1 (0.7–1.8) 3.4 (3.1–3.7) 2.4 (2.2–2.6)
a

Adjusted for BMD T-score, ethnicity, education, self-rated health status, maternal or family history of fracture, estrogen use, body weight, current corticosteroid use, smoking status, menopause before age 40 years, and alcohol use

b

Adjusted variables included age plus the covariates listed above